Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial

被引:20
作者
Armani, Rachel G. [1 ]
Carvalho, Aluizio B. [1 ]
Ramos, Christiane, I [1 ]
Hong, Valeria [2 ]
Bortolotto, Luiz A. [2 ]
Cassiolato, Jose Luiz [3 ]
Oliveira, Natacha F. [4 ]
Cieslarova, Zuzana [5 ]
do Lago, Claudimir L. [5 ]
Klassen, Aline [4 ]
Cuppari, Lilian [1 ]
Raj, Dominic S. [6 ]
Canziani, Maria Eugenia F. [1 ]
机构
[1] Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil
[2] Univ Sao Paulo, Heart Inst, Sao Paulo, Brazil
[3] CARDIOS, Adv Cardiol Equipment, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Dept Chem, Diadema, Brazil
[5] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil
[6] George Washington Univ, Div Kidney Dis & Hypertens, Washington, DC USA
基金
巴西圣保罗研究基金会;
关键词
chronic kidney disease; endothelial dysfunction; flow-mediated dilatation; fructooligosaccharide; gut microbiota; CHRONIC KIDNEY-DISEASE; BOUND UREMIC TOXINS; OXIDATIVE STRESS; INDOXYL SULFATE; BRACHIAL-ARTERY; GUT MICROBIOME; PREBIOTICS; ATHEROSCLEROSIS; INTERLEUKIN-6; VASODILATION;
D O I
10.1093/ndt/gfaa335
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Microbiota-derived uremic toxins have been associated with inflammation that could corroborate with endothelial dysfunction (ED) and increase cardiovascular risk in patients with chronic kidney disease (CKD). This trial aimed to evaluate the effect of the prebiotic fructooligosaccharide (FOS) on endothelial function and arterial stiffness in nondialysis CKD patients. Methods. In a double-blind controlled trial, 46 nondiabetic CKD patients were randomized to receive 12 g/day of FOS or placebo (maltodextrin) for 3 months. Total p-cresyl sulfate (PCS) and indoxyl sulfate by high-performance liquid chromatography, urinary trimethylamine N-oxide by mass spectrometry, C-reactive protein, interleukin-6 (IL-6), serum nitric oxide and stroma-derived factor-1 alfa were measured at baseline and at the end of follow-up; endothelial function was assessed through flow-mediated dilatation (FMD) and arterial stiffness by pulse wave velocity (PWV). Results. The mean (+/- standard deviation) age of the study participants was 57.6 +/- 14.4 years, with an estimated glomerular filtration rate of 21.3 +/- 7.3 mL/min/1.73 m(2). During the follow-up, regarding the inflammatory markers and uremic toxins, there was a significant decrease in IL-6 levels (3.4 +/- 2.1 pg/mL versus 2.6 +/- 1.4 pg/mL; P = 0.04) and a trend toward PCS reduction (55.4 +/- 38.1 mg/L versus 43.1 +/- 32.4 mg/L, P = 0.07) only in the prebiotic group. Comparing both groups, there was no difference in FMD and PWV. In an exploratory analysis, including a less severe ED group of patients (FMD >= 2.2% at baseline), FMD remained stable in the prebiotic group, while it decreased in the placebo group (group effect P = 0.135; time effect P = 0.012; interaction P = 0.002). Conclusions. The prebiotic FOS lowered circulating levels of IL-6 in CKD patients and preserved endothelial function only in those with less damaged endothelium. No effect of FOS in arterial stiffness was observed.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 44 条
[1]   Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction [J].
Anderson, TJ .
HEART FAILURE REVIEWS, 2003, 8 (01) :71-86
[2]   Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease [J].
Barreto, Daniela V. ;
Barreto, Fellype C. ;
Liabeuf, Sophie ;
Temmar, Mohammed ;
Lemke, Horst-Dieter ;
Tribouilloy, Christophe ;
Choukroun, Gabriel ;
Vanholder, Raymond ;
Massy, Ziad A. .
KIDNEY INTERNATIONAL, 2010, 77 (06) :550-556
[3]   Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease [J].
Borges, Natalia A. ;
Barros, Amanda F. ;
Nakao, Lia S. ;
Dolenga, Carla J. ;
Fouque, Denis ;
Mafra, Denise .
JOURNAL OF RENAL NUTRITION, 2016, 26 (06) :396-400
[4]  
Canty TG, 1999, CIRCULATION, V100, P361
[5]   Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction [J].
Catry, Emilie ;
Bindels, Laure B. ;
Tailleux, Anne ;
Lestavel, Sophie ;
Neyrinck, Audrey M. ;
Goossens, Jean-Francois ;
Lobysheva, Irina ;
Plovier, Hubert ;
Essaghir, Ahmed ;
Demoulin, Jean-Baptiste ;
Bouzin, Caroline ;
Pachikian, Barbara D. ;
Cani, Patrice D. ;
Staels, Bart ;
Dessy, Chantal ;
Delzenne, Nathalie M. .
GUT, 2018, 67 (02) :271-283
[6]   Probiotics and prebiotics: A brief overview [J].
Chow, J .
JOURNAL OF RENAL NUTRITION, 2002, 12 (02) :76-86
[7]   Capillary electrophoresis with dual diode array detection and tandem mass spectrometry to access cardiovascular biomarkers candidates in human urine: Trimethylamine-N-Oxide and L-carnitine [J].
Cieslarova, Zuzana ;
Magaldi, Mariana ;
Barros, Lucelia Alcantara ;
do Lago, Claudimir Lucio ;
Oliveira, Daniel Rossado ;
Helfenstein Fonseca, Francisco Antonio ;
Izar, Maria Cristina ;
Lopes, Aline Soriano ;
Maggi Tavares, Marina Franco ;
Klassen, Aline .
JOURNAL OF CHROMATOGRAPHY A, 2019, 1583 :136-142
[8]   Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force [J].
Corretti, MC ;
Anderson, TJ ;
Benjamin, EJ ;
Celermajer, D ;
Charbonneau, F ;
Creager, MA ;
Deanfield, J ;
Drexler, H ;
Gerhard-Herman, M ;
Herrington, D ;
Vallance, P ;
Vita, J ;
Vogel, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :257-265
[9]   Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease [J].
Cosola, Carmela ;
Rocchetti, Maria Teresa ;
Cupisti, Adamasco ;
Gesualdo, Loreto .
PHARMACOLOGICAL RESEARCH, 2018, 130 :132-142
[10]   Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals [J].
Cosola, Carmela ;
De Angelis, Maria ;
Rocchetti, Maria Teresa ;
Montemurno, Eustacchio ;
Maranzano, Valentina ;
Dalfino, Giuseppe ;
Manno, Carlo ;
Zito, Annapaola ;
Gesualdo, Michele ;
Ciccone, Marco Matteo ;
Gobbetti, Marco ;
Gesualdo, Loreto .
PLOS ONE, 2017, 12 (01)